Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of chronic kidney disease in the US ...

The Philippine Health Insurance Corporation (PhilHealth) has substantially enhanced its Z Benefit Package for Peritoneal Dialysis, this time with separate packages for adult and pediatric patients, ...

Some clinical trials have validated a new perspective on continuous renal replacement therapy (CRRT) in combination with oXiris haemofilter to more effectively enhance endotoxins clearance and ...

Its growth is driven by the rising prevalence of kidney and urological disorders. The global market for nephrology and urology devices is projected to reach $39.3b by 2030, at a compound annual growth ...

The trial is assessing the efficacy and safety of the company's selective cytopheretic device (SCD) in conjunction with continuous renal replacement therapy (CRRT). The trial aims to enrol 200 adult ...

VolitionRx (VNRX) announced the results of a large-scale study which shows that its Nu.Q NETs H3.1 biomarker is an independent predictor of ...

IN A major win for dialysis patients, the Philippine Health Insurance Corp. (PhilHealth) has significantly enhanced its Z ...

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with a rate reaching almost PH ...

Researchers assessed whether early albumin use among patients with septic shock and kidney impairment upon hospital admission reduced in-hospital mortality or the need for renal replacement ...